AI model could spare diabetes patients from invasive kidney biopsies

NCT ID NCT07672639

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study uses machine learning to tell apart diabetic kidney disease from other kidney diseases in people with type 2 diabetes. Researchers analyzed data from over 2,200 patients across 14 medical centers to build a model that uses routine clinical and lab information. The goal is to provide a noninvasive way to diagnose kidney problems, potentially avoiding the need for a kidney biopsy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could provide a noninvasive way to diagnose kidney disease in diabetes patients, reducing the need for risky biopsies.

What could go wrong

This is a retrospective study using existing data, so results may not apply to all populations. The model's accuracy depends on data quality and may not replace biopsy in all cases.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome diabetic kidney disease type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Tongren Hospital

    Beijing, Beijing Municipality, 100730, China